NuCana PLC reports results for the quarter ended in March - Earnings Summary

NuCana

16/05/2024 22:01

* NuCana PLC  NCNA.OQ  reported a quarterly adjusted loss
of 3
pence​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of
£-3.75.  The mean expectation of four analysts for the quarter
was for a loss of $2.77 per share. Wall Street expected
results to range from £-3.50 to $-2.00 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * NuCana PLC's reported EPS for the quarter was a loss of 3
pence​.
    * The company reported a quarterly loss of £6.84 million.
    * NuCana PLC shares had fallen by 41.8% this quarter and
lost 48.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 23%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for NuCana PLC is
$125.00 
This summary was machine generated from LSEG data May 16 at
09:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -2.77          -0.03          Beat
 Dec. 31 2023      -2.56          -3.50          Missed
 Sep. 30 2023      -2.51          -3.25          Missed
 Jun. 30 2023      -3.22          -2.50          Beat